Drug for Enlarged Prostate Cuts Cancer Risk, Too

Tumors stop growing or even shrink in study
By Kevin Spak,  Newser Staff
Posted Apr 1, 2010 11:31 AM CDT
Drug for Enlarged Prostate Cuts Cancer Risk, Too
Avodart is seen in this promotional image.

A drug designed to shrink enlarged prostates may also be able to reduce the risk that at-risk men will develop prostate cancer, according to a new study. The drug dutasteride, sold under the brand name Avodart, was found to reduce the risk of cancer by roughly 25%. Researchers report seeing tumors stop growing or even shrink. GlaxoSmithKline says it intends to ask the FDA for permission to market Avodart as a risk reducer.

“The question may be, why isn’t every man taking one of these drugs?” one doctor told the LA Times. “There seems to be very little downside.” Well, here’s a reason: The same study suggests that dutasteride might increase the risk of heart failure. In the test group of 6,700 men, 30 on the drug developed heart failure, compared to 16 on a placebo, the AP reports. (Read more prostate cancer stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.